M&T Bank’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-41,491
Closed -$2.33M 1741
2016
Q4
$2.33M Sell
41,491
-1,458
-3% -$84K 0.01% 492
2016
Q3
$2.65M Sell
42,949
-5,167
-11% -$338K 0.02% 460
2016
Q2
$3.05M Buy
48,116
+104
+0.2% +$6.54K 0.02% 418
2016
Q1
$2.88M Buy
48,012
+45,030
+1,510% +$2.75M 0.02% 443
2015
Q4
$209K Buy
+2,982
New +$211K ﹤0.01% 1488
2015
Q3
Sell
-6,745
Closed -$529K 1957
2015
Q2
$529K Sell
6,745
-13
-0.2% -$1.01K ﹤0.01% 1180
2015
Q1
$516K Sell
6,758
-145
-2% -$10.7K ﹤0.01% 1172
2014
Q4
$460K Buy
6,903
+88
+1% +$5.86K ﹤0.01% 1253
2014
Q3
$434K Buy
+6,815
New +$421K ﹤0.01% 1337

Other funds holding PJP

M&T Bank's PJP Position: Q1 2017 in Review

M&T Bank sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2017, closing a stake of 41,491 shares — an estimated $2.33M sold.

M&T Bank first reported a position in PJP in Q3 2014 and held it in 9 quarters. The position peaked at $3.05M in Q2 2016. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2017.

  • M&T Bank reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
  • M&T Bank sold 41,491 Invesco Pharmaceuticals ETF shares in Q1 2017, an estimated $2.33M.
  • M&T Bank first reported a position in Invesco Pharmaceuticals ETF in Q3 2014 and held it in 9 quarters.
  • M&T Bank's Invesco Pharmaceuticals ETF position peaked at $3.05M in Q2 2016.
  • 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2017.

Based on M&T Bank's 13F filing for Q1 2017, filed 10 May 2017.